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Abstract 
Objectives: Critical closing pressure (CrCP) is the arterial blood pressure (ABP) threshold, 
below which small arterial vessels collapse and cerebral blood flow ceases. Here we aim to 
compare three methods for CrCP estimation in scenario of a controlled increase in intracranial 
pressure (ICP) induced by infusion test performed in patients with suspected normal pressure 
hydrocephalus (NPH).  
Methods: Computer recordings of directly measured intracranial pressure (ICP), ABP and 
Transcranial Doppler cerebral blood flow velocity (CBFV), from 37 NPH patients who 
underwent infusion tests, were retrospectively analyzed.  The CrCP was calculated with three 
methods. With first harmonics ratio of the pulse waveforms of ABP and CBFV (CrCPA)  and 
two methods based on a model of cerebrovascular impedance, as a function of cerebral 
perfusion pressure (CrCPinv), and as a function of ABP (CrCPninv) d. 
Results: During controlled rise of ICP all three estimators of CrCP increased significantly  
(p < 0.05). During infusion tests the strongest correlation between ICP  and CrCP was found 
for CrCPinv (median R was 0.41). For the other methods, the median of the correlation 
coefficient was less than 0.24. There is good agreement between three methods of CrCP 
calculation with mutual correlation coefficients being greater than 0.8 (p << 0.05). For CrCPA 
method, negative values can be encountered for about 20% of all results. Negative values of 
CrCP were not observed in estimators based on cerebrovascular impedance. 
Conclusion: Invasive critical closing pressure is most sensitive to variations in ICP and CPP 
and can be used as an indicator of the cerebrospinal and cerebrovascular system status during 
infusion tests. All methods give similar results in response to ICP changes. In case of 
individual CrCP measurement for each patient, CrCPA, may provide negative, non-
physiological values.  
Key words: critical closing pressure, wall tension, intracranial pressure, cerebral 
autoregulation, infusion test. 
Introduction 
 Critical closing pressure (CrCP) is the arterial blood pressure (ABP) threshold, below 
which small arterial vessels collapse and blood flow ceases. It was first described by Burton 
[1]. Theoretically, cerebral CrCP is the sum of intracranial pressure (ICP) and vascular wall 
tension (WT) [2]. With the introduction of transcranial Doppler ultrasonography it became 
possible to assess CrCP noninvasively by comparing the waveforms of cerebral blood flow 
velocity (CBFV) and ABP [3, 4, 5]. One of the methods, proposed by Aaslid [6] is based on 
linear regression analysis between single pulse of CBFV and ABP as an intercept point of the 
regression line with the X axis (ABP) [7]. Alternatively, the fundamental harmonics of the 
pulse waveforms of ABP and CBFV can be used [8]. These methods however may provide an 
inaccurate estimation of CrCP as they can produce negative values of CrCP that cannot be 
interpreted physiologically [9]. Recently Varsos et al. [10] proposed a new methodology for 
CrCP estimation based on a cerebrovascular impedance model [11] as a function of cerebral 
perfusion pressure (CPP), ABP, cerebrovascular resistance (CVR), arterial compliance (Ca), 
and heart rate (HR). This multiparameter descriptor of CrCP has been extensively explored in 
patients with different cerebrovascular derangements such as: vasospasm after subarachnoid 
hemorrhage [12], traumatic brain injury [13] or in patients suffering from hydrocephalus [14]. 
Important advantage of this method of CrCP calculation is the fact that it is not providing the 
non–physiological negative values of pressure, as was in the case of Aaslid’s method.  
In this study we aim to compare three methods for CrCP estimation in scenario of a controlled 
increase of ICP induced by the infusion test performed in patients with suspected normal 
pressure hydrocephalus (NPH). It was previously showed that an increase in CrCP is related 
to increase in ICP [3]. However, it is unknown whether and to what extent the noninvasive 
and invasive methods of CrCP estimation can be used interchangeably in scenario of 
controlled rise in ICP.  
Material and Method 
Patients 
 Thirty seven patients with entry diagnosis of normal pressure hydrocephalus were 
studied. The median age of the patients was 57.0 years (quartile range: 37.0–64.0 years). On 
the basis of imaging examination (median width of third cerebral ventricle was 13.64 mm, 
quartile range: 10.15–17.22 mm) and clinical symptoms they have been admitted to the 
Hydrocephalus Clinic, Addenbrooke’s Hospital, Cambridge, UK in order to undergo the 
infusion test. The evidence of white matter ischemia on cranial imaging occurred in seven 
patients. Tests are performed as a standard clinical procedure. Patients are individually 
consented and anonymized digital recordings of monitored variables were post–processed  
as a part of clinical audit. 
Infusion test procedure 
The CSF space was accesed by a lumbar puncture. Spinal needle was inserted between the 
third and fourth lumbar vertebrae and used for both ICP measurements and saline fluid 
infusion. The needle was connected to an infusion pump and to the pressure transducer, from 
which the signal was transferred to the standard invasive pressure inputof  bed–side monitor.. 
After about 10 minutes of the baseline pressure measurement the infusion was started. The 
test was performed with a constant–rate infusion, 1.5 ml min−1 or 1.0 ml min−1 if the baseline 
pressure was greater than 13 mmHg. The infusion was continued until a new steady state of 
ICP (plateau) reached, or until ICP safety limit of 40 mmHg was achieved.  
Data acquisition and analysis 
 Cerebral blood flow velocity (CBFV) was measured from the middle cerebral artery 
(MCA) with a 2 MHz probe and monitored with the Transcranial Doppler (Neuroguard, 
Medasonics, Fremont, CA). Arterial blood pressure was measured non–invasively by 
Finapress finger cuff (Ohmeda, Englewood, CO). Raw signals were digitized using an 
analog–digital converter (DT2814, Data Translation, Marlboro, CA) sampled at a frequency 
of 50 Hz, recorded by WREC software (Wojciech Zabolotny, Warsaw University of 
Technology) and re–analysed using ICM+ software (Cambridge Enterprise, Cambridge, UK, 
http://www.neurosurg.cam.ac.uk/icmplus/). The amplitudes of the fundamental harmonics of 
ABP, CBFV and ICP were derived using 10 seconds discrete Fourier transformations. Heart 
rate (HR) was assessed as frequency associated with the first harmonic of ABP. All the 
calculations were performed over a 10 s window.  
Calculation of Critical Closing Pressure  
Method 1 (CrCPA) 
 CrCP was determined using first harmonics ratio of the pulse waveforms of ABP and 
CBFV according to following formula [8]: 
𝐶𝑟𝐶𝑃𝐴 = 𝐴𝐵𝑃𝑚𝑒𝑎𝑛 −
𝐴𝑚𝑝𝐴𝐵𝑃
𝐴𝑚𝑝𝐶𝐵𝐹𝑉
∙ 𝐶𝐵𝐹𝑉𝑚𝑒𝑎𝑛 (1)  
Where: ABPmean – mean value of ABP; AmpABP and AmpCBFV – amplitudes of the 
fundamental harmonics of ABP and CBFV, respectively. 
Model-based estimation of CrCP: 
 To calculate multiparameter model of CrCP [10] it is necessary to estimate 
cerebrovascular resistance (CVR) and compliance (Ca). CVR represents the resistance of 
small cerebral arteries and it can be estimated using TCD mean blood flow velocity (CBFV), 
and mean cerebral perfusion pressure (CPP = meanABP – meanICP): 
𝐶𝑉𝑅 =
𝑚𝑒𝑎𝑛𝐶𝑃𝑃
𝑚𝑒𝑎𝑛𝐶𝐵𝐹𝑉 ∙ 𝑆𝑎 
 (2)  
The arterial compliance (Ca) represents the change of arterial blood volume in response to 
change in arterial pressure and can be estimated as: 
𝐶𝑎 =
𝐴𝑚𝑝𝐶𝑎𝐵𝑉 ∙ 𝑆𝑎
𝐴𝑚𝑝𝐴𝐵𝑃
 (3)  
In equations 2 and 3, Sa represents the cross–sectional area of the insonated vessel. Obtaining 
of amplitude of the fundamental harmonic of cerebral arterial blood volume (CaBV) is 
described in detail in work [12] and presented in appendix.  
Method 2 (CrCPinv) 
 CrCPinv is calculated based on mathematical model of cerebrovascular impedance [10] 
and expressed by equation 4. Details of the mathematical analysis are given in appendix: 
𝐶𝑟𝐶𝑃𝑖𝑛𝑣 = 𝐴𝐵𝑃 −
𝐶𝑃𝑃
√(𝐶𝑉𝑅 ∙ 𝐶𝑎 ∙ 𝐻𝑅 ∙ 2𝜋)2 + 1
 (4)  
Method 3 (CrCPninv) 
 In some clinical scenarios, when there is no need or possibility to monitor ICP, CrCP 
can be calculated from equation 5 with CPP approximated by ABP: 
𝐶𝑟𝐶𝑃𝑛𝑖𝑛𝑣 = 𝐴𝐵𝑃 ∙ (1 −
1
√(𝐶𝑉𝑅𝑛𝑖𝑛𝑣 ∙ 𝐶𝑎 ∙ 𝐻𝑅 ∙ 2𝜋)2 + 1
) (5)  
 
Where CVRninv is cerebrovascular resistance calculated from equation 2 with CPP 
approximated by ABP. This a simple modification of formula 4, taking ICP = 0. 
  
Wall Tension 
According to Burton’s idea [1, 2] vascular wall tension can be expressed as the difference 
between CrCP and intracranial pressure and represent active vasomotor tone: 
𝑊𝑇 = 𝐶𝑟𝐶𝑃 − 𝐼𝐶𝑃 (6)  
WT was calculated using two methods, the Aaslid’s CrCP conception (WTA) and 
cerebrovascular impedance methodology (WTinv). Having available CrCP and WT, the ratio 
of these parameters was determined.  
Statistical analysis 
 To determine whether the data is normally distributed the Shapiro–Wilk test was used. 
Nonparametric Wilcoxon test was utilized to examine the significance of a difference in 
analysed parameters between baseline and plateau phase of the test. The significance level of 
all tests was set at 0.05. Results are presented as median value ± quartile range (QR). Bland–
Altman method was used to determine the agreement between three methods of CrCP 
calculation.  
 
Results 
 The changes in ICP, ABP, CPP, CBFV between baseline and plateau phase of the test 
and  calculated variables: CrCPA, CrCPinv, CrCPninv, WTA, WTinv along with ratios of WT and 
CrCP are presented  in table 1.  
During lumbar infusion mean ICP increased significantly (p < 0.0001) by 12.29 ± 6.31 mmHg 
from baseline to plateau level. ABP was significantly higher during infusion when compared 
with baseline, whereas the CPP and CBFV were significantly lower. Difference between 
baseline and plateau level for CPP and CBFV is 7.90 ± 10.16, p = 0.001 and 2.67 ± 2.49,  
p < 0.0001, respectively.  
Table 1 - Median and quartile range (median ± QR) of measured and calculated 
variables from baseline and plateau level 
N=34 Baseline Plateau p-value 
ICP [mm Hg] 6.81 ± 7.27 19.76 ± 11.16 < 0.0001 
ABP [mm Hg] 95.12 ± 36.36 100.40 ± 33.74 0.0085 
CPP [mm Hg] 86.98 ± 26.59 81.87 ± 32.54 0.0010 
CBFV [cm/s] 87.02 ± 28.81 50.34 ± 17.58 < 0.0001 
CrCPinv [mm Hg] 44.99 ± 16.11 52.72 ± 20.74 < 0.0001 
CrCPninv [mm Hg] 44.73 ± 22.12 48.90 ± 24.29 0.0001 
CrCPA [mm Hg] 33.39 ± 27.86 38.03 ± 33.68 0.0003 
WTinv [mmHg] 38.15 ± 17.98 31.48 ± 21.58 0.0002 
WTA [mmHg] 28.76 ± 28.22 15.24 ± 33.59 0.0105 
(WT/CrCP)inv [mmHg] 0.87 ± 0.12 0.65 ± 0.19 < 0.0001 
(WT/CrCP)A [mmHg] 0.87 ± 0.17 0.48 ± 0.39 < 0.0001 
 
Critical Closing Pressure calculated using three methods 
Following the rise in ICP, median CrCP obtained with all three methods significantly 
increased by 7.78 ± 6.00, p < 0.0001, for CrCPinv, 5.89 ± 4.66, p < 0.0001 for CrCPninv and by 
9.38 ± 9.87, p = 0.0001, in case of CrCPA. However, the values of Aaslid’s estimator were 
lower than impedance methods by 10.80 ± 20.56, p < 0.0001, in baseline and by 12.45 ± 
16.99, p < 0.0001, in plateau. 
Results obtained with all 3 methods of CrCP calculation were strongly  correlated with each 
other. The strongest correlation was found between CrCPinv and CrCPninv (R = 0.9675, p < 
0.0001). The associations between CrCPA and either CrCPinv or CrCPninv were also significant 
but correlation coefficients were weaker (CrCPinv vs. CrCPA, R = 0.8398, p < 0.0001 and 
CrCPninv vs. CrCPA, R = 0.8295, p < 0.0001 ). The Bland–Altman plots obtained for pooled 
data from both phases of the test (baseline and infusion) demonstrate a moderately good 
agreement between the Aaslid’s method and both model–based methods (invasive and  
non–invasive ones) for CrCP calculation (figures 2a and 2b). The biggest discrepancies were 
seen when the CrCPA demonstrated negative values. On the other hand a very good agreement 
was found between invasive and non–invasive model–based methods (figure 2c). The mean 
difference between the CrCP values obtained with the two (invasive and  
non–invasive) methods was about 4.5 mmHg. 
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Figure 1 - Scatterplots of relationship between critical closing pressure calculated by  
A) non–invasive model–based method (CrCPninv) vs. Aaslid’s method (CrCPA),  
B) invasive model–based method (CrCPinv) vs. Aaslid’s method (CrCPA) C) invasive vs. 
non–invasive model–based method (CrCPinv vs. CrCPninv). 
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Figure 2 – The Bland–Altman plots for comparing difference between A) CrCPninv and 
CrCPA B) CrCPinv and CrCPA C) CrCPinv and CrCPninv for all measurement points. 
Horizontal lines are drawn at the mean difference and ± 2 times standard deviation (SD) 
of the differences.  
  
Correlation analysis between CrCP obtained with three methods and ICP was also performed 
based on data recorded in each individual patient. The results were highly variable (see  
table 2). Examples of a good and bad correlation are shown on figure 3.  
Table 2 - Median, minimum, maximum and quartile range of correlation coefficients 
between ICP and CrCP calculated based on three methods. 
 Median Minimum Maximum 
Inter – Quartile 
Range 
R between  
CrCPinv and ICP 
0,4055 -0,5269 0,8310 0,4444 
R between  
CrCPninv and ICP 
0,2384 -0,5170 0,6844 0,3337 
R between CrCPA 
and ICP 
0,2355 -0,2380 0,7054 0,4667 
In 7 patients (20.58 %) correlation coefficient between ICP and CrCP had a negative values. 
Negative values occurred most often in case of CrCPninv. In 4 patients correlation coefficient 
between ICP and three estimators of CrCP had negative values.  
A 
 
 
 
B 
 
 
 
Figure 3 - Example of good (A) and bad (B) correlation between ICP and CrCP with the 
corresponding time plots.  
As a result, the highest correlation coefficient for ICP and CrCPinv was found.  
It was also observed that changes in CrCP from baseline to plateau ICP (ΔCrCP) were 
significantly correlated to changes in ICP (ΔICP), as demonstrated an example in figure 4. 
Correlations were observed in all three methods: ΔICP and ΔCrCPA, R = 0.4451; p = 0.0075, 
ΔICP and ΔCrCPninv, R = 0.3901, p = 0.0205, ΔICP and ΔCrCPinv, R = 0.4349, p = 0.0090.  
 
Figure 4 – Correlation between changes in invasive estimator of critical closing pressure 
(ΔCrCPinv) and changes in intracranial pressure (ΔICP).  
Wall Tension calculated using two methods 
WT showed a tendency to decrease due to compensating vasodilatation. The values of WTA 
were lower than impedance–model based estimator (p < 0.0001). Correlation analysis 
between WT and cerebrovascular resistance (Figure 5) demonstrated that impedance–model 
based WT was positively correlated to CVR (R = 0.6761, p < 0.0001). We found weaker but 
significant correlation between CVR and WTA (R = 0.2445, p = 0.0358). The ratio of WT and 
CrCP significantly decreased for both methods. WT/CrCP ratios were almost identical for two 
methods. During the test WT/CrCP ratio tends to decrease. Difference between plateau level 
and baseline for ratio of (WT/CrCP)inv was 0.2025 ± 0.1280 (p < 0.0001) and for ratio of 
(WT/CrCP)A was 0.3159 ± 0.2677 (p < 0.0001). 
Changes in in cerebrovascular resistance (ΔCVR) is strongly  correlated with changes in wall 
tension calculated by invasive model–based method ΔWTinv R = 0.7564, p < 0.0001. 
However, the observed correlation between the changes in CVR and Aaslid’s estimator of 
wall tension, although significant, were only moderate.  
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Figure 5 – Scatterplots of relationship between A) cerebrovascular resistance (CVR) and 
invasive model–based wall tension (WTinv) B) CVR and Aaslid’s estimator of wall 
tension (WTA). 
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Figure 6 – Correlation between changes in A) cerebrovascular resistance (ΔCVR) and 
invasive model–based wall tension (ΔWTinv) and B) CVR and Aaslid’s estimator of wall 
tension (ΔWTA). 
 
Discussion 
 The aim of this study was to compare three methods of CrCP calculation. It is difficult 
to decide which method is better. We have shown a close relationship between the values of 
CrCP obtained using impedance model–based methods (invasive and non–invasive one) and 
based on Aaslid’s equation. The mean difference between the CrCP values obtained with 
impedance–model based methods (invasive and non–invasive) was about 4.5 mmHg.  
CrCP calculation methods are relatively well correlated, although non–invasive CrCP 
expresses changes in ICP in weaker degree. Moreover in individual patients the absolute 
difference between these estimators was the smallest in case CrCPinv and CrcPninv (Bland–
Altman plots). Correlation between CrCP from Aaslid’s equation and invasive/non–invasive 
CrCP was undoubtedly lower. The existence of negative CrCPA values caused discrepancies 
between the methods. CrCPA was lower than impedance model–based estimators. This is 
caused by methodological limitations of Aaslid formula. During controlled increase in ICP, 
CrCPA rendered negative values in situations of changes in amplitude and mean values of 
CBFV and/or ABP. The issue of low and negative values of CrCPA has been a known 
drawback in cases such as hyperemia or vasospasm [9, 13]. Therefore physiological 
interpretation  of CrCPA is sometimes difficult.  
Changes in critical closing pressure (ΔCrCP) are shown to be positively correlated to changes 
in intracranial pressure (ΔICP). During infusion tests, rising ICP leads to a significant increase 
in CrCP. We can observe contrasting effect of ICP on CrCP and wall tension (WT). Rising 
ICP causes CrCP and WT to change in opposite directions (CrCP increasing and WT 
decreasing due to compensatory to decreasing CPP vasodilatation). Past studies performed 
under various conditions [15, 16] have demonstrated that both changes in ICP and WT cause 
changes in estimated CrCP. Changes in CrCP related to rise in ICP are partially damped by 
vasodilation (decrease in WT). This is first reason why CrCP is not the best estimator of ICP. 
Changes in cerebrovascular resistance, which is one of the most important mechanisms of 
cerebral homeostasis, are shown to be positively correlated to changes in WTinv.  
Relationship between CrCP, WT and ICP could also be demonstrated through the WT/CrCP 
ratio, which was shown to be significantly associated with changes in ICP. During infusion 
the ratio of WT and CrCP decreases, which suggests that the CrCP in intracranial 
hypertension becomes more active estimator of ICP. On the other hand, the ratio WT/CrCP 
can be used as measure of vasodilatation. WT decreased significantly when CPP decreased, 
which may be interpreted as an effect of cerebral vasodilatation. 
Conclusions 
 There was a significant correlation between the analyzed methods of CrCP 
determining. All three indices were in agreement, although the best agreement between 
impedance model–based methods (invasive and non–invasive) was performed. The strongest 
correlation between ICP and CrCP occurs in case of application invasive impedance model–
based method, which can be explained due to the use of ICP in the CrCPinv calculation 
formula. Rising ICP lead to increases in all three estimators od CrCP with vascular wall 
tension (WT) decreasing, signifying vasodilatation. Correlation between CrCP and ICP may 
be disturbed by decrease in WT during infusion.  
  
Appendix 
In impedance – based methods, impedance spectrum across the frequencies of cardiac cycle 
(ω) is given by parallel set of cerebrovascular resistance (CVR) and arterial compliance (Ca). 
Therefore, modulus of impedance could be expressed as: 
|𝑍(𝜔)| =
𝐶𝑉𝑅
√𝐶𝑉𝑅2 ∙ 𝐶𝑎
2 ∙ 𝜔2 + 1
 
(1)  
where ω symbolizes circular frequency (2Π*frequency). 
In used model, the amplitude of fundamental harmonic of cerebral blood flow velocity could 
be expressed as a function of cerebrovascular impedance: 
𝐴𝑚𝑝𝐶𝐵𝐹𝑉 =
𝐴𝑚𝑝𝐴𝐵𝑃
|𝑍(𝑓𝐻𝑅)|
 (2)  
where |Z(fHR)| represents modulus of cerebrovascular impedance at the heart rate frequency 
(fHR). AmpCBFV and AmpABP symbolize first harmonics amplitudes of cerebral blood flow 
velocity and arterial blood pressure, respectively. 
One can apply the same model to evaluate the mean value of fundamental cerebral blood flow 
velocity (CBFV) at the theoretical heart rate of zero. CBFV simulates a direct current, arterial 
compliance is saturated, and impedance (|Z(0)|) is a function of cerebrovascular resistance 
(CVR): 
𝐶𝐵𝐹𝑉 =
𝐶𝑃𝑃
|𝑍(0)|
=
𝐶𝑃𝑃
𝐶𝑉𝑅
 (3)  
where CPP is cerebral perfusion pressure and it is equal to difference between ABP and 
intracranial pressure (ICP). 
Critical closing pressure (CrCP) could be evaluated based on equations (1), (2), (3) and 
Aaslid’s formula [8], and could be expressed as: 
𝐶𝑟𝐶𝑃𝑖𝑛𝑣 = 𝐴𝐵𝑃 −
𝐶𝑃𝑃
√(𝐶𝑉𝑅 ∙ 𝐶𝑎 ∙ 𝐻𝑅 ∙ 2𝜋)2 + 1
 (4)  
In above formula, pulsation of CPP may be approximated by pulsation of ABP, in case of 
there is no need or possibility to monitor ICP. 
To calculate model–based CrCP [10], estimation of CVR and Ca is required. CVR represents 
the resistance of small cerebral arteries and it can be estimated using TCD mean blood flow 
velocity (CBFV), and mean cerebral perfusion pressure (CPP): 
𝐶𝑉𝑅 =
𝐶𝑃𝑃
𝐶𝐵𝐹𝑉 ∙ 𝑆𝑎 
 (5)  
The Ca represents the change of arterial blood volume in response to change in arterial 
pressure and can be estimated as: 
𝐶𝑎 =
𝐴𝑚𝑝𝐶𝑎𝐵𝑉 ∙ 𝑆𝑎
𝐴𝑚𝑝𝐴𝐵𝑃
 (6)  
In equations 5 and 6, Sa represents the cross–sectional area of the insonated vessel. Obtaining 
the amplitude of the fundamental harmonic of cerebral arterial blood volume (CaBV) [12] 
could be evaluated based on pulsatile changes of CBFV. Therefore, it could be derived by 
using a 10 – second discrete Fourier transformation of CaBV time series. 
CaBV can be approximated by sampling instant and average values of cerebral blood flow 
velocity: 
𝐶𝑎𝐵𝑉(𝑛) = 𝑆𝑎 ∙ ∑(𝐶𝐵𝐹𝑉𝑎(𝑖) − 𝑚𝑒𝑎𝑛𝐶𝐵𝐹𝑉𝑎(𝑖))∆𝑡(𝑖)
𝑛
𝑖=𝑚
 (7)  
where n is the number of the samples, CBFVa(i) – sampled cerebral blood flow velocity, and 
Δt(i) is the time interval between the consecutive samples. 
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